EV Biologics, Inc. (YECO)

EV Biologics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	2	10	12	6	36	0
Market Cap Growth	-4.12%	-16.75%	109.88%	-83.80%	11100.26%	-95.45%
Enterprise Value	3	12	35	27	36	10
PE Ratio	-	-8.07	-0.58	-15.10	-365.06	-3.28
PS Ratio	41.37	209.11	-	49.22	-	-
PB Ratio	-3.06	-6.07	-0.89	0.81	4.75	0.22
P/FCF Ratio	-1.74	-3.08	-0.59	-0.32	369.83	-0.85
P/OCF Ratio	-1.76	-3.11	-0.59	8.39	369.83	0.21
EV/Sales Ratio	71.54	237.08	-	226.52	-	-
EV/EBITDA Ratio	-10.52	-24.00	-58.68	-1110.18	-364.03	-105.26
EV/EBIT Ratio	-	-	-	-	-	-13.19
EV/FCF Ratio	-2.18	-3.49	-1.66	-1.45	368.78	-27.32
Debt / Equity Ratio	-0.80	-0.89	-1.64	3.00	0	6.89
Debt / EBITDA Ratio	-2.18	-3.09	-38.43	-893.67	-	-101.99
Debt / FCF Ratio	-0.45	-0.45	-1.09	-1.17	-	-26.47
Quick Ratio	0.13	0.19	0.02	0.03	0.07	0.16
Current Ratio	0.13	0.19	0.02	0.03	0.07	0.22
Asset Turnover	0.11	0.11	0	0.00	0	0
Return on Equity (ROE)	52.84%	75.27%	152.21%	-5.37%	-1.30%	-6.75%
Return on Assets (ROA)	-307.52%	-293.51%	-184.32%	-1.24%	-1.09%	-0.32%
Return on Capital (ROIC)	178.51%	256.12%	-6.67%	-0.08%	-1.30%	-0.86%
Earnings Yield	-49.13%	-12.39%	-171.41%	-6.62%	-0.27%	-30.51%
FCF Yield	-163.74%	-32.49%	-169.67%	-317.26%	0.27%	-
Buyback Yield / Dilution	-41.52%	-41.52%	-	-	-12.45%	-166.49%
Total Shareholder Return	-41.52%	-41.52%	-	-	-12.45%	-166.49%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.